stem cells | Stem Cells Course

Tag Archives for " stem cells "

How Exosome Therapy Differ from Stem Cell Therapy

Exosomes are potent microvesicles released by adult mesenchymal stem cells. They have the ability to help restore cells in the body by improving cell to cell communication.

Exosomes are not cells, and they are smaller than cells. When compared to adult stem cells, exosomes have much more growth factors which give them a better clinical and aesthetic potential than stem cells.

It’s a cell-free cell therapy, this makes it safer compared to other cellular therapy, because there’s no risk of rejection in graft Vs host.

Unlike some other cellular therapies, exosomes do not produce host graft reactions, because they do not carry HLA genetic information and are not cells but extracts of the cells (released by cells).

Exosomes have a superior regenerative capacity, because they are obtained from newborn umbilical cord tissue mesenchymal cells, which means they have not been exposed to any contaminating or toxic agent because our cells are as healthy as our body.

Exosomes improve the signaling between cells, thereby making them useful to revitalize, rejuvenate, restore, and cause anti-inflammatory effects in the body.

When compared to autologous adult stem cells, exosomes have much more healthy growth factors which gives them a better clinical and aesthetic potential than stem cells.

Exosomes are less complicated products to transport because the cells used in cellular therapy must be applied to the patient very quickly because they are live cells. In the laboratory, once they are thawed the doctors have limited time to apply them. However, with exosomes, they last longer, because as they are proteins they do not denature and can last for longer periods.

Exosomes is a superior product to autologous treatments because they do not require a surgical procedure, they come in a vial that can be injected directly, significantly reducing the risk and complications of a surgical procedure.

It is a superior product to autologous stem cell therapy because the patient’s cells have the same age and the same quality. For example, if a patient is a smoker and intoxicated, obviously the health of his cells is not the best. That is why the most indicated product is a donor product that is pure and free of toxins.

Mesenchymal cell-derived exosomes are preferably used in regenerative medicine. These cells are excellent regenerative cells due to their multipotent nature, therefore MSCs derived exosomes are superior to other exosomes products.

The Cellgenic lyophilized exosomes are derived from mesenchymal cells, which makes it superior to other exosome products, because mesenchymal cells have superior and excellent regenerative capacity.

This is why exosome therapy, especially Cellgenic lyophilized exosomes should be a doctor’s first choice.

How much does exosome therapy cost?

Exosome therapy is the new buzz in the regenerative medicine industry because of how it can repair and regenerate your cells and tissues.

Exosome therapy is safer compared to other cellular therapy because it’s a cell-free therapy with no risk of rejection.

Exosome therapy will be beneficial to you if you’re dealing with conditions such as sport injuries, tissue regeneration,  hair loss, erectile dysfunction, chronic pain and so many other applications . 

In this article, you’ll be learning the cost of exosome therapy and how you can benefit from exosome therapy.

How the cost of exosome therapy is determined

All cells produce exosomes, which are microvesicles that contain biochemical and genetic information. 

Hence, the cost of an exosome product (used in exosome therapy) will depend on what type of cell line (raw tissue source) used to extract the exosomes.

The first factor to determine the cost of an exosome product depends on the quality of the tissue source.

The most commonly used tissue types are cord blood, amniotic fluid and mesenchymal cell cultures.

Exosomes derived from mesenchymal cell cultures are the most difficult to obtain but offer the greatest therapeutic potential.

How much does exosome therapy cost?

The average cost of exosome therapy is $4,900, but the price can be anything from $3,500 – $6,500.

It’s also important to note that the price depends on your specific needs and your treatment plan, as decided by the doctor.

The doctor will schedule a consultation with you to determine your personalized treatment plan.

The exosome therapy can either be given as an IV infusion or as localized injections, depending on the purpose of the therapy.

Exosomes are very useful to revitalize, rejuvenate, restore, and reduce inflammations in the body.

Here are some ways you can benefit from exosome therapy

Hair loss therapy: If you’re in the early stages of hair loss, with exosome therapy you can regenerate your hair whether you’re a man or woman. After exosome therapy, you’ll start seeing new hair growth in as little as two to three months with very significant results showing 6 months or 1 year later.

Chronic pain: In case you’re experiencing chronic pain due to degenerative conditions such as arthritis, exosomes can help to subdue the pain by regenerating the cells and helping the body work better.

Degenerative conditions: If you’re struggling with degenerative medical conditions such as osteoarthritis and musculoskeletal injuries, exosome therapy can help your body repair the damage done to your cells by these conditions, prevent them from getting better, and help you to feel better.

Skin therapy: exosome therapy can reduce inflammation in the skin by improving the strength and elasticity of the skin.

Anti-aging: if you would like to retain your youthful glow, exosome therapy can make you feel young again by rejuvenating your skin due to its ability to reverse the cells dying due to aging.

Where can you get exosome therapy?

Cellular hope institutes provide exosome therapy for patients looking for better outcomes for various conditions.

The exosomes used at Cellular Hope Institute are obtained from umbilical cord tissue that is discarded after a new birth , which means these Exosomes have not been exposed to any contaminating or toxic agent because our cells are as healthy as our body. This gives it a higher capacity to regenerate your cells and tissues.

Culture Expanded MSCs

Mesenchymal Stem Cells (MSCs) are the most commonly used cells in stem cell therapy and regenerative medicine, due to their high and multi-potency. Mesenchymal Stem Cells (MSCs) can be isolated from different tissues in the body.

In this article, you’ll be learning about culture-expanded MSCs, how MSCs can be expanded, The potency of MSCs and the type of cells they can differentiate into.

What are culture expanded Mesenchymal Stem cells?

Mesenchymal stem cells are high potent cells used for cellular therapy and isolated from different parts of the body. Mesenchymal stem cells can be used to improve the patient outcome in diseases and conditions such as autoimmune diseases, degenerative diseases, nerve damage, diabetes mellitus, bone problems etc.

For every patient, millions of mesenchymal stem cells are needed and the exact amount varies according to disease, route of administration, administration frequency, weight, and age of patient.

Mesenchymal stem cells are expanded in a culture media, on a large scale in order to obtain the required quantity of cells needed for cellular therapy.

Culture expanded MSCs: How does it work?

Expanding Mesenchymal stem cells in a media involves step by step process of isolation and expansion.

Mesenchymal Stem Cells Isolation

Mesenchymal stem cells can be isolated from different tissues in the human body such as adipose tissues, dental pulp, human bone marrow, umbilical cord tissue, umbilical cord blood, peripheral blood and synovium.

Mesenchymal stem cells are expanded in culture to increase their yield and amplify their desired functions and potency.

Although the population of Mesenchymal Stem Cells obtained will vary from donor to donor, here are some steps to follow:

· Acquire fresh tissue extracts in strictly aseptic conditions, to maintain purity.

· To remove any cell clusters, you have to filter the cell suspension with a 70-mm filter mesh

· Use a centrifuge to roll the cells for about 5 minutes at 500g

·  Suspend the cells again the cells to measure the cell viability and yield using Trypan blue exclusion

· Use in T75 culture dishes to culture the cells in 10 mL of complete MSC medium at a density of 25 × 106 cells/mL. You can then go on to Incubate the plates at 37 °C with 5% CO2 in a humidified chamber without any interruption.

· When it’s past 3 h, remove the non-adherent cells that accumulate on the surface of the dish by changing the medium and replacing it with 10 mL fresh complete medium.

·  After an additional 8 h of culture, add 10ml fresh complete medium as a replacement for the existing medium. You’ll have to repeat this step every 8 h for up to 72 h of initial culture.

· Cells can be frozen in MSC growth media plus 10% DMSO (D2650) at a density of 2X106 cells/vial.

Expansion of Mesenchymal Stem Cells in a culture media

Culture expanded mesenchymal cells undergo various stages from the preparation of the culture plate, thawing of Mesenchymal stem cells, and the actual expansion of Mesenchymal stem cells.

The reason behind the cultural expansion of Mesenchymal stem cells is to get them to differentiate into other cell types such as osteoblast, adipocyte, and mesenchymal stromal cells.

In preparation, to expand MSCs in a culture media, you need a culture ware. You can get one plastic or glassware plate and coat it with a sufficient amount of 0.1% gelatin. Don’t forget to aspirate the gelatin solution from the coated plate or flask before you use it.

The next step involves the thawing of the Mesenchymal stem cells, and here are a few steps for you to follow:

After the recommended culture medium and coated culture ware is ready and on standby, remove the vial of Mesenchymal Stem Cells from liquid nitrogen and incubate in a 37C water bath and pay close attention to it, until all the cells are completely thawed. The extent of completely thawed frozen cells and how fast, are what determines the cell viability.

Once the cells have thawed completely, take steps to avoid contamination by disinfecting the walls with 70% ethanol, before you proceed to the next step.

Place the cells in a hood, and carefully transfer the cells to a sterile tube with a pipette (1 or 2ml pipette), Do this in such a way to prevent bubbles.

Then, add drops of Mesenchymal Stem cell expansion medium that have been pre-warmed to 37C to the tube containing the Mesenchymal stem cells.

Be careful to take your time when adding the medium to avoid osmotic shock which could lead to decreased viability.

Proceed to mix the suspension slowly by pipetting up and down two times while avoiding any bubbles.

Place the tube in a centrifuge and centrifuge the tube at 300 x g for 2-3 minutes to roll the cells, and you should not vortex the cells.

After this, then decant as much of the supernatant as possible. These steps are necessary to remove residual cryopreservative (DMSO).

Suspend the cells in a total volume of 10 mL of Mesenchymal Stem Cell Expansion Medium again or any alternative of choice, pre-warmed to 37 °C, containing freshly added 8 ng/mL FGF-2 (F0291).

The next step involves placing the cell suspension onto a 10-cm tissue culture plate or a T75 tissue culture flask.

Maintain the cells in a humidified incubator at 37 °C  with 5% CO2.

The next day, exchange the medium with fresh Mesenchymal Stem Cell Expansion Medium (pre-warmed to 37 °C) containing 8 ng/mL FGF-2*. Replace with fresh medium containing FGF-2 every two to three days thereafter.

Isolate the cells when they are approximately 80% confluent, using Trypsin-EDTA and passaged further or frozen for later use.

Expansion of Mesenchymal Stem Cells

Once the cells are actively proliferating and have reached a confluence of approximately 80% (before 100%), you should subculture the cells.

Then remove the medium from the 10-cm tissue culture plate containing the confluent layer of human mesenchymal stem cells, carefully and apply 3-5 mL of Trypsin-EDTA Solution, before proceeding to incubate in a 37 °C incubator for 3-5 minutes.

Crosscheck the culture to see if all the cells are completely detached. Then, add 5 mL Mesenchymal Stem Cell Expansion Medium to the plate.

Swirl the plate mildly to mix the cell suspension. Transfer the separated/isolated cells to a 15 mL conical tube.

Centrifuge the tube at 300 x g for 3-5 minutes to pellet the cells.

Throw the supernatant away and apply 2 mL Mesenchymal Stem Cell Expansion Medium (pre-warmed to 37 °C) containing 8 ng/mL FGF-2 to the conical tube and completely suspend the cells again. Remember not to vortex the cells.

Then, use a hemocytometer to count the number of cells.

Plate the cells at a density of 5,000-6,000 cells per cm2 into the appropriate flasks, plates, or wells in a Mesenchymal Stem Cell Expansion Medium containing 8 ng/mL FGF-2.

Cells can be frozen in MSC growth media plus 10% DMSO (D2650) at a density of 2X106 cells/vial.

Functions of Culture Expanded MSCs

Mesenchymal stem cells are required to be expanded in order for them to be used clinically for therapeutic purposes.

The culture expanded MSCs can be induced to differentiate into adipocytes, osteocytes, hepatocytes, chondrocytes, tenocytes and cardiomyocytes.

Because of its potential to differentiate into different kinds of cells in the body, it can be used to manage liver problems, heart problems, joint and bone problems etc.

Mesenchymal stem cells are also used in tissue regeneration and modulation of the immune system. They possess anti apoptotic, angiogenic, anti fibrotic, and anti-oxidative properties.

However, the quantity of MSCs isolated from body tissues is not enough for clinical and therapeutic applications.

This is why MSCs are expanded in culture to increase their yield for desired therapeutic effect.

Why cellular therapies have become a standard in clinics that are betting on biological medicine

Cellular therapy is fast becoming a standard therapy in many regenerative clinics today.  Many doctors are no longer questioning the safety and effectiveness of stem cell therapy. This is because various stem cell studies are already describing the benefits of stem cells for patients who are living with chronic and autoimmune health conditions.

This article will be talking about why stem cell therapy have become a standard therapy in clinics, the paracrine effect of stem cells, and other reasons why doctors are adopting stem cells in their clinics.

Benefits of stem cell therapy

Stem cell therapy is an important innovation in medicine because of its regenerative power in the human body. Most disease states are characterized by damaged cells, tissues and organs, which is where stem cell therapy comes in. In stem cell therapy, stem cells are administered into the human body and it replaces the cells damaged by disease or health disorders.

Stem cell research has revealed two major ways of using stem cells to rebuild defective and damaged cells. One of these ways can be seen in procedures like bone marrow transplant, where stem cells are used to replace the damaged cells by engraving, and they then differentiate into the proper cell type. Another mechanism relies on the paracrine effect of stem cells. This procedure of stem cell therapy involves using stem cells isolated from a donor to stimulate the patient’s cells to repair damaged tissues.

Additionally, unlike traditional therapy, stem cells have a wide application. Stem cell therapy is used to manage various degenerative diseases, autoimmune disorders, birth defects, and the research is still ongoing for so many other health conditions where stem cells have shown potential.

Also, there is currently a high demand for aesthetic medicine. Stem cell therapy is a proven alternative to other forms of cosmetology such as plastic surgery. Hence, dermatologists are turning to stem cell therapy to administer anti-aging procedures, skin rejuvenation, hair therapy, micro-needling etc.

The Paracrine effect of stem cells

The paracrine effect of stem cells is one of the most outstanding effects of stem cells. It involves using donor cells to stimulate endogenous repair by harnessing the regenerative power of the human body. It is a mechanism of tissue regeneration that has created new possibilities for managing various conditions using stem cell therapy.

The cells that trigger a paracrine response are; mesenchymal cells, umbilical cord blood, umbilical cord tissue, adipose (fat) tissue and blood cells from a donor’s bone marrow.

The paracrine effect occurs when the donor’s cells send the damaged or defective cells signals to induce self regeneration and repair by secreting some factors and proteins. One of the mechanism by which this paracrine effect is initiated, involves the secretion of cytokines and regulatory proteins by the damaged patient’s cells, these cytokines and proteins act as mediators to stimulate an immune response that attracts the donor cells, this causes the donor cells to release proteins and factors that stimulate the patient’s cells to promote cell proliferation, increase vascularization and blood flow to the areas that needs to heal, while reducing inflammation.

Moreover, research has shown that the paracrine effect of stem cells prevents damaged and diseased cells from dying. They are also therapeutically useful in autoimmune diseases and preventing transplant rejection due to the immune suppression effect they have.

Is stem cell therapy effective?

Doctors are always looking for ways to provide the best possible treatment to their patients, and that is why many clinics are embracing stem cell therapy as a standard, due to its many advantages.

Stem cell therapy is one of the most effective and safest therapy patients can receive, when compared to other existing treatment options.  Stem cell therapy is used in promoting patient outcomes in a lot of disease conditions that were previously poorly treated by other alternatives.

Again, as new potentials and ways of applying stem cells are being discovered, doctors are beginning to maximize these benefits in their clinics. Some conditions that are currently treated by stem cells include autoimmune conditions, immunotherapy Car-T cells, chronic obstructive pulmonary disease, neurodegenerative conditions, osteoarthritis, spinal cord injury, aesthetics/anti-aging, sports medicine, autism and multiple sclerosis.

Another reason clinics are adopting stem cell therapy as a standard therapy is because it is easy to administer. A lot of machines such as GCELL {Insert link} which makes the harvesting and processing of stem cells easy and fast, have made the procedures easily adaptable by doctors.

Furthermore, stem cell therapy reduces the treatment and recovery time associated with surgical procedures and other treatment options. This alone is a big factor in why stem cells are becoming a standard therapy in clinics.

Therapeutic uses of stem cells vs traditional medicine

Existing stem cell research has shown how the regenerative effect of stem cells is defining the future of medicine. The major advantage of stem cell therapy over conventional medication-based therapy is its safety. Stem cell therapy is aimed at treating the cause of the disease while traditional medicine targets the symptoms.

 Another problem with traditional medical therapy is that it introduces another problem while trying to solve the existing one. As a doctor, you always run the risk of causing harm with each prescription because of various adverse effects that could lead to major organ damage of the kidney, liver etc.  On the other hand, patients already know this and they are actively seeking better alternatives, this is why stem cell therapy is fast becoming a standard therapy in clinics.

Moreover, doctors will always be concerned about whether their patients are taking their medications or not. The burden of drug compliance and adherence associated with traditional medical therapy is not always easy to navigate. This is why effective treatment options like stem cell therapy have become a standard therapy in clinics. It only requires the patients having a procedure that repairs and restores damaged cells and tissues in the most natural way.

If you would like to become certified in regenerative medicine using stem cells and other cellular therapy, contact us.

2 ISSCA introduces new stem cell training courses web page for regenerative medicine practitioners

 
 
 
 
 
 
 
ISSCA has launched a new stem cell training web page designed to offer free information and resources to help physicians choose a training program best suited to their unique needs.
MIAMI, June 26, 2018—The International Society for Stem Cell Application (ISSCA) has launched a new stem cell training course web page, coordinated by Global Stem Cells Group affiliate Stem Cell Training, designed to help physicians access free information and resources on the newest instruction and training options in regenerative medicine training.
The new web page is designed to help physicians interested in adding stem cell procedures to grow their medical practice or enhance career advancement opportunities find stem cell training program options to enable them to find a training program best suited to their individual needs.  ISSCA’s variety of stem cell training opportunities include:
Online stem cell training course, ISSCA’s cutting-edge online course that teaches physicians everything they need to know to add adult stem cell-based procedures to their existing practice, or confidently transition to a regenerative medicine center. Offering the convenience of training from a home or office computer, this course prepares physicians in all the theoretical and practical knowledge needed to effectively and expertly administer stem cell therapies to patients, including harvesting and isolating stem cells.
ISSCA’s online training positions physicians to open their own stem cell center practice and join ISSCA’s expansive network. Successful completion of the online training course allows physicians to immediately begin offering cutting-edge regenerative medicine procedures to patients, establish themselves as experts in their fields, and enjoy the benefits of the growing regenerative medicine industry.
Hands-on stem cell certification training courses, ISCCA’s intensive, two-day hands-on training course scheduled at various international locations provides attending physicians with expert instruction on autologous stem cell therapies in the field of regenerative medicine. Participants learn techniques and protocols for harvesting and isolating stem and regenerative cells from adipose tissue, bone marrow, and /or peripheral blood from live patients and administering the cells back to the patient
Course curriculum consists of comprehensive theoretical lectures and home study education, and two days of didactic and clinical experience. One day of post-educational on-site clinical assistance is also available upon request.
Onsite training, ISSCA’s personalized, hands-on, onsite stem cell training brings stem cell specialists to your practice or clinic, anywhere in the world, to provide one-on-one training tailored to your practice’s specific requirements—saving time and money. The onsite training program offers participants a unique opportunity to grow their practice and achieve their specific practice goals by offering practice-specific regenerative medicine treatments to patients in their medical office or clinical setting.
The onsite training course provides participating practices with personalized theoretical information and hands-on training along with ongoing support for their clinical practice. Applications and protocols are provided by a Stem Cells Training faculty member with extensive experience in laboratory and clinical practice.

ISSCA’s onsite training specifications include:
1. Equipment and supply delivery. The Stem Cell Training team
delivers and sets up all equipment and supplies necessary for the            training session to take place and will leave the physician’s team
fully qualified to start its own stem cell treatment practice.

2. Expert trainers. ISSCA’s onsite stem cell training course takes a highly visual and interactive approach. Expert trainers teach and supervise the hands-on process using live patients and different protocols for the extraction, isolation, and application of PRP, adipose- and bone marrow-derived stem cells.
3. Multimedia access. ISSCA provides physicians participating in its onsite training program access to its library of high-resolution, step-by-step procedure videos and ongoing online and telephone support for clinical equipment, inquiries or concerns for the practice’s future use and reference.
Fellowship in cell therapy and tissue engineering. Recognizing the need for knowledge of stem cell protocols among physicians and healthcare professionals, ISSCA and Stem Cell Training created the Fellowship of Stem Cell Therapy and Tissue Engineering program. The fellowship focuses on stem cell therapies involving the potential replacement of cells or organs that are diseased, injured, infirmed, ailing or aged
In this modular training program, a group of experienced academic scholars involved in stem cell transplantation present a series of topics covering the general principles and practices of stem cell
biology and evidence-based treatments that physicians can apply to optimize the health of their patients. Fellowship course details and objectives include:
• A detailed program offering hands-on experience in stem cell characterization and laboratory applications
• An opportunity to learn cell culture processes including plating, trypsinization, harvesting, and cryopreservation
• Gaining the ability to understand and apply quality control tests including cell count, viability, flow cytometry, endotoxin, mycoplasma, and sterility
• Learning to perform CGMP functions including clean room maintenance, gowning, and environmental monitoring
• Establishing insight on relevant applications of stem cell processing and regulations that apply to a certified facility
• Receiving the tools necessary to implement regulatory and clinical guidelines when setting up a GMP facility
• Providing participants with copies of presentations, procedural protocols, and all forms associated with a GMP facility, as well as case books and full protocols for approximately 30 indications
• Demonstrating the ability to perform clinical procedures including lipoaspirate and bone marrow isolation, and reintroduction of stem cells for various indications
The new ISSCA stem cell training web page also features an informative blog that publishes four new articles in the field of regenerative medicine weekly.
To learn more, visit the ISSCA stem cell training web page, email info@stemcellsgroup.com, or call 305-560-5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
Stem cell training web page launch

Global Stem Cells Group names Mehmet Veli Karaaltın, M.D. to Advisory Board

 

 

 

 

 

 

 

(Image: Mehmet Veli Karaaltın, M.D.)

MIAMI, Jan. 18, 2018—Global Stem Cells Group CEO Benito Novas has named Mehmet Veli Karaaltın, M.D., Associate Professor of Plastic, Aesthetic, and Reconstructive Surgery, (European Board Certified), and hand surgery, head, and maxillofacial surgery specialist to the GSCG Advisory Board Faculty.

Karaaltın practices in Istanbul, Turkey.

Born in Iraq-Kirkuk in 1972, Karaaltın moved to the United States with his family, living in West Lafayette, Indiana and Los Angeles until 1988, when he moved to Istanbul.

After graduating from Istanbul University’s Cerrahpaşa English Medical Faculty, Karaaltın received a national examination from Hacettepe University in Ankara, Turkey, where he was 12th out of 25000 doctoral candidates.  In 2012, he passed and completed all ID exams required by the European Society of Plastic Surgery. He ​​is a member of the European Council of Plastic Reconstructive and Aesthetic Surgery and the International Society of Aesthetic Plastic Surgery (ISAPS).

In addition to his work in aesthetic applications, Karaaltın is also known for his work in microvascular free flaps, nerve transfers, facial surgery, and tissue transplants.

Karaaltın also practices cellular therapy and tissue regeneration for healing diabetic wounds, severe burns, and Buerger’s disease. He is one of only a few physicians in the world who offer surgical treatment for Lymphedema-Elephant Disease with microvascular lymph node transfer. In addition, Karaaltın uses

3-D technology to perform aesthetic rhinoplasty.

“It is a pleasure to welcome Dr. Karaaltın to the Global Stem Cells Group Advisory Board,” says GSCG  CEO Benito Novas. “He brings a wealth of knowledge in aesthetic regenerative medicine to the table, and we look forward to a long and productive alliance.”

To learn more, visit the Global Stem Cells Group website, email inf@stemcellsgroup.com, or call +1 305 560 5337.

About Global Stem Cells Group:

Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.

Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.

 

Mehmet Veli Karaaltın, M.D.

ISSCA President Daeyong Kim, Ph.D. Names Junaid Sayed, M.D. President of ISSCA’s U.S. Chapter

 

 

 

 

 

 

 

(Image: Junaid A. Syed, M.D.)

ISSCA President Daeyong Kim, Ph.D., has named Junaid Sayed, M.D. president of ISSCA’s U.S. chapter.

MIAMI, Jan. 18, 2018—International Society for Stem Cell Application (ISSCA) President Daeyong Kim, Ph.D., has named Junaid Sayed, M.D. president of ISSCA’s U.S. chapter. Sayed is Board Certified physician with extensive training in aesthetic medicine.

As president of the U.S. chapter, Sayed will represent and promote ISSCA activities the USA, including ISSCA’s Stem Cell Certification Training and Stem Cell Conference events. He will also share the latest information on regenerative medicine clinical applications with the U.S, medical community.

“We are happy to have Dr. Sayed represent ISSCA in the U.S., and as a collaborator in our efforts to introduce new clinical applications to the medical community,” says Kim. “He brings a wealth of experience and expertise to the ISSCA organization.”

To learn more about ISSCA, visit the stemcellglobal.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About ISSCA:

ISSCA 2018 training agenda

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

 

 

 

 

Global Stem Cells Group Subsidiary Stem Cell Center Network to open new facility in Puerto Rico

 

 

 

 

 

 

 

MIAMI, Jan. 15, 2018—Global Stem Cells Group (GSCG) subsidiary Stem Cell Center Network, the world’s largest collective support and advisory network of regenerative medicine clinics and physicians, has announced the opening a new facility in San Jose, Puerto Rico in January 2018.

Stem Cell Center Puerto Rico will provide stem cell treatments for a variety of conditions, including osteoarthritis, erectile dysfunction, and urinary incontinence.  Adimarket, also a subsidiary of GSCG, will provide Stem Cell Center Puerto Rico with state-of-the-art products and technology, such as the Integrated Stem Cell Workstation

Global Stem Cells Group CEO Benito Novas named Juan Colon, M.D. to head Stem Cell Center Puerto Rico as medical director. Colon is a urologist who has spent the past year working to help prostate cancer patients. He earned his medical degree from Recinto de Ciencias Médicas in San Juan and trained in the latest regenerative medicine protocols in December 2017 at Stem Cell Center San Jose, Costa Rica.

The Stem Cell Center Network has aggressively launched and rapidly expanded new fellowship programs, events, and other regenerative medicine events over the past five years and currently has members practicing in 25 countries.

The new San Juan center will treat patients with a variety of degenerative conditions with emphasis on osteoarthritis, according to Novas.  

For more information, visit the Stem Cell Center Network website, the Global Stem Cells Group website, email info@stemcellsgroup.com, or call +1305 560 5337.

About Global Stem Cells Group:

Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.

Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.

About Stem Cell Center Network:

Stem Cell Center Network, a division of Global Stem Cells Group, is an international network of medical practitioners dedicated to bringing stem cell therapies to patients worldwide.
Network physicians are experts in their fields and believe that stem cell treatments are to the future of medicine. Each Network physician is dedicated to providing the best treatments and contributing to the global store of regenerative medicine knowledge and research.

About Adimarket:

Adimarket, Inc.,
a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and healthcare professionals.

Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.

ISSCA to Conduct Regenerative Medicine Training in Mexico City Feb.9-10, 2018

 

 

 

 

 

 


ISSCA will conduct the next regenerative medicine certification training course in Mexico City, Feb. 9-10, 2018. The two-day course focuses on harvesting adipose and bone marrow stem cells from patients in a clinical environment.

MIAMI, Jan. 15, 2018—The International Society for Stem Cell Application (ISSCA) announced plans to hold its next regenerative medicine certification training course in Mexico City, Feb. 9 – 10, 2018.

The two-day, hands-on training course will focus on harvesting adipose and bone marrow stem cells from patients in a clinical environment. Qualified physicians learn skills that can be used to treat patients in their practices, and for career advancement. The course provides participating physicians with training in stem cell applications to treat a variety of conditions.

Participating physicians will also receive access to the online stem cell training course to review all content and procedures introduced in the 2-day clinical training course, patient forms and guidelines, procedure informed consent forms, didactic lectures, training booklets, and more.

ISSCA’s stem cell certification course offers hands-on, personalized training in harvesting stem cells from a live patient. ISSCA has trained more than 2,000 physicians worldwide. The course is only available to eight physicians per training, so it is important to sign up early to reserve a seat.

The ISSCA regenerative medicine training course was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells.

Stem cell therapies continue to revolutionize the healthcare industry and help improve the quality of life for patients.

To learn more about the ISSCA certification training course and register to participate, visit the Stem Cell Training Course website, email info@stemcellsgroup.com, or call 305-560-5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

 

 

 

 

ISSCA Announces Launch of the First Bilingual (English and Spanish) Regenerative Medicine Newsletter

 

 

 

 

 

 


ISSCA has announced plans to launch the first bilingual (English and Spanish) regenerative medicine newsletter.
 

MIAMI, Jan. 15,  2018—The International Society for Stem Cell Application (ISSCA) will launch the first bilingual (English and Spanish) regenerative medicine newsletter January 23, 2018. The monthly newsletter will be available for free to email subscribers and shared through ISSCA social media channels.

The newsletter will include three sections:

  1. Regenerative Medicine Business News
  2. Regenerative Medicine Research and clinical applications
  3. Upcoming Regenerative Medicine Training

Regenerative Medicine Business News will provide the latest updates on policies, legislative, regulatory and reimbursement initiatives to support research and development of regenerative medicine products, and business development and investor information on opportunities in the fast-growing stem cell and regenerative medicine market.

Regenerative Medicine Research and clinical applications will follow the latest findings on regenerative medicine research and development—from tissue engineering to cell therapies, and the different challenges involved in live tissue handling and manufacturing. In addition, the newsletter will include information on the latest clinical applications of regenerative medicine therapies.

The newsletter will also include schedules and registration information on upcoming regenerative medicine training and certification courses, along with registration information.

To subscribe to ISSCA’s newsletter, send an email request with your contact information to info@stemcellsgroup.com.

To learn more, visit the ISSCA website, email info@stemcellsgroup.com, or call 305-560-5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

1 2 3 6